Great Plains Communications Secures $500 Million in Financing
December 20, 2024 11:44 ET
|
Great Plains Communications
Blair, Nebraska, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Great Plains Communications (GPC), a leading Midwestern telecommunications provider, announced today the successful closing of $500 million in...
Western Investment Company Closes Outstanding $1.1 Million of the $30 Million Over-Subscribed Private Placement
December 19, 2024 07:00 ET
|
The Western Investment Company of Canada
Western closes $30 million over-subscribed private placement upon receipt of $1.1 million that was previously outstanding
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
December 16, 2024 16:01 ET
|
Candel Therapeutics
NEEDHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
December 13, 2024 14:55 ET
|
Palvella Therapeutics Inc.
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for...
PharmAla Announces Private Placement
December 13, 2024 09:25 ET
|
PharmAla Biotech
PharmAla announces private placement financing
Candel Therapeutics Announces Pricing of Public Offering
December 12, 2024 23:00 ET
|
Candel Therapeutics
NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...
Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street
December 12, 2024 02:00 ET
|
Essential Pharma
Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street Provides significant resources to...
Angitia Biopharmaceuticals Announces $120 Million Series C Financing
December 11, 2024 08:00 ET
|
Angitia Incorporated Limited
- Financing led by Bain Capital Life Sciences with significant participation from existing and new investors - Proceeds will support the development of AGA2118, AGA2115, AGA111 and other pipeline...
Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering
December 10, 2024 07:20 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF) (“Cardiff Oncology” or the “Company”), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop...
CytoSorbents Announces Rights Offering
December 09, 2024 07:00 ET
|
CytoSorbents
CytoSorbents Announces Rights Offering Exclusive to Stockholders Who Hold or Have Bought CTSO Common Stock by Market Close on Friday, December 13, 2024